Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
HJB and Mabspace Biosciences' Development and Manufacturing Agreement for Novel Humanized Claudin18.2 Monoclonal Antibody Accomplished FDA and NMPA IND Clearance 2020-05-08 23:00
Bridge Biotherapeutics Announces the IND Clearance of BBT-176, an EGFR TKI for NSCLC, in South Korea 2020-05-08 07:30
Scientific Evidence Shows Everyday Hygiene Is Essential to Help Prevent the Spread of Infections, Reveals New Paper From The Global Hygiene Council 2020-05-08 07:01
DERMALOG Fever Detection at UKE Hamburg 2020-05-07 19:57
Lipidor Presents Updated Project Plan - Initiates Phase III study of AKP02 in-House 2020-05-07 18:20
Lianhua Qingwen Receives Product Listing Approval from Singapore HSA 2020-05-07 15:14
TWi Biotechnology Receives Canada Health Approval for AC-1101 Phase 1 CTA 2020-05-07 14:06
Sai Life Sciences Joins the Global 'COVID Moonshot' Project 2020-05-07 09:00
Tyvyt® (Sintilimab Injection) Combined with Gemzar® (Gemcitabine for Injection) and Platinum Chemotherapy Met the Predefined Primary Endpoint in the Phase 3 ORIENT-12 Study as First-Line Therapy in Patients with Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer 2020-05-07 07:30
Yiling Pharmaceutical Releases Financial Report for Q1 2020, Covid-19 TCM Lianhua Qingwen Research and Achievements Drive Growth 2020-05-06 17:52
Venturis Therapeutics, Inc. Announces its Applications for Four New Patents Related to the Use of Therapeutic Angiogenesis in the Treatment of Illnesses Related to the COVID-19 Virus, as Well as Illnesses Related to Other Viruses 2020-05-06 09:26
Antengene Announces Expansion of Partnership with Karyopharm in Asia Pacific Markets 2020-05-05 20:30
AGC Biologics Partners with Faron Pharmaceuticals to Manufacture Cancer Treatment 2020-05-05 20:30
Ajinomoto Bio-Pharma Services Announces Manufacturing Partnership with CytoDyn for Drug Product Used in COVID-19 Clinical Trials 2020-05-05 20:05
Tessa Therapeutics Announces New Executive Leadership 2020-05-05 00:00
Ascentage Pharma's Core Drug Candidate HQP1351 Granted Orphan Drug Designation by the US FDA for the Treatment of Patients with Chronic Myeloid Leukemia 2020-05-04 18:30
Yiling Pharmaceutical to Increase Productivity of Lianhua Qingwen 2020-05-04 08:15
Reminder: Deadline To File Claims In The Purdue Pharma L.P. Bankruptcy Is June 30, 2020 2020-05-02 01:19
Trio Pharmaceuticals, Inc. and Ajinomoto Bio-Pharma Services Enter into a Development Collaboration for a Novel Antibody Therapeutic 2020-04-30 20:05
Data From Merck at ASCO 2020 to Showcase Significant Clinical Advances in Cancer Care 2020-04-30 20:00
1 296 297 298 299 300 412